ACM
EXAS

Anfield Capital Management’s Exact Sciences EXAS Stock Holding History

Anfield Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-154
Closed -$10.6K – 446
2024
Q1 		$10.6K Buy
+154
New +$9.74K 0.01% 153
2020
Q1 		– Sell
-812
Closed -$78K – 195
2019
Q4 		$78K Buy
+812
New +$71.4K 0.03% 186

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Anfield Capital Management's EXAS Position: Q2 2024 in Review

Anfield Capital Management sold out of Exact Sciences (EXAS) in Q2 2024, closing a stake of 154 shares — an estimated $10.6K sold.

Anfield Capital Management first reported a position in EXAS in Q4 2019 and held it in 2 quarters. The position peaked at $78K in Q4 2019. 543 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.

  • Anfield Capital Management reported no remaining Exact Sciences position as of Q2 2024 after selling out during the quarter.
  • Anfield Capital Management sold 154 Exact Sciences shares in Q2 2024, an estimated $10.6K.
  • Anfield Capital Management first reported a position in Exact Sciences in Q4 2019 and held it in 2 quarters.
  • Anfield Capital Management's Exact Sciences position peaked at $78K in Q4 2019.
  • 543 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.

Based on Anfield Capital Management's 13F filing for Q2 2024, filed 31 Jul 2024.